ELI LILLY AND COMPANY v. TEVA PHARMACEUTICALS USA, INC.
1:06-cv-01017
Overview
Parties
Defendant
TEVA PHARMACEUTICALS USA, INC. Operating Company
Represented By
12 Attorneys ListedFROST BROWN TODD LLC
FROST BROWN TODD LLC, 201 North Illinois Street, Suite 1900
FROST BROWN TODD LLC
FROST BROWN TODD LLC, 201 North Illinois Street, Suite 1900
LOEB & LOEB LLP
321 North Clark Street, Suite 2300
LOEB & LOEB LLP
321 North Clark Street, Suite 2300
KENYON & KENYON LLP
One Broadway, New York, NY 10004-1007
LOEB & LOEB LLP
321 North Clark Street, Suite 2300, Chicago, IL 60610
KENYON & KENYON
KENYON & KENYON, One Broadway
KENYON & KENYON LLP
One Broadway, New York, NY 10004-1007
LOEB & LOEB LLP
321 North Clark Street, Suite 2300
LOEB & LOEB LLP
321 North Clark Street, Suite 2300
LOEB & LOEB LLP
321 North Clark Street, Suite 2300, Chicago, IL 60654
LOEB & LOEB, LLP
321 North Clark Street, Suite 2300, Chicago, IL 60654
Consol Plaintiff
ELI LILLY AND COMPANY Operating Company
Represented By
12 Attorneys ListedFINNEGAN HENDERSON FARABOW GARRETT & DUNNER LLP
3300 Hillview Avenue, Palo Alto, CA 94304
FINNEGAN, HENDERSON, FARABOW GARRETT & DUNNER, L.L.P.
FINNEGAN, HENDERSON, FARABOW GARRETT & DUNNER, L.L.P., 901 New York Avenue, N.W.
FINNEGAN HENDERSON FARABOW GARRETT & DUNNER, LLP
901 New York Avenue, NW, Washington, DC 20001
FINNEGAN, HENDERSON, FARABOW, GARRETT, & DUNNER,LLP
901 New York Ave. NW, Washington, DC 2001-4413
FINNEGAN HENDERSON FARABOW GARRETT & DUNNER LLP
11955 Freedom Drive, Reston, VA 20190
FINNEGAN, HENDERSON, FARABOW, GARRETT & DUNNER LLP
901 New York Ave. NW, Washington, DC 20001
BARNES & THORNBURG LLP
11 South Meridian Street, Indianapolis, IN 46204
FINNEGAN HENDERSON FARABOW GARRETT & DUNNER LLP
901 New York Avenue, NW, Washington, DC 20001
FINNEGAN HENDERSON FARABOW GARRETT & DUNNER, LLP
11955 Freedom Drive, Reston, VA 20190
FINNEGAN HENDERSON FARABOW GARRETT & DUNNER L.L.P.
FINNEGAN HENDERSON FARABOW GARRETT & DUNNER L.L.P., 901 New York Ave., N.W.
BARNES & THORNBURG LLP
11 South Meridian Street, Indianapolis, IN 46204
FINNEGAN HENDERSON FARABOW GARRETT & DUNNER, LLP
901 New York Avenue, NW, Washington, DC 20001
Court & Judges
Court
District Court, S.D. Indiana (insd)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360° RadarMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
No Co-Pending Disputes Detected in Current Index
There are no other active filings for this patent family across our indexed PTAB, U.S. Court, UPC, or EPO databases.
Patents Involved
There are 9 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
USRE39050
Methods of use for inhibiting bone loss and lowering serum cholesterol
|
Filed: 2003-02-27
Issued: 2006-03-28
|
Expired (Term Ended)
Expires: 2023-02-27
|
|
|
USRE38968
Methods for inhibiting bone loss using 6-hydroxy-2-(4-hydroxyphenyl)-benzo[b]thien-3-yl-4-[2-(piperidin-1-yl) ethoxyphenylimethanone hydrochloride
|
Filed: 2003-02-27
Issued: 2006-02-07
|
Expired (Term Ended)
Expires: 2023-02-27
|
|
|
USRE39049
Methods for inhibiting bone loss
|
Filed: 2003-02-27
Issued: 2006-03-28
|
Expired (Term Ended)
Expires: 2023-02-27
|
|
|
US6906086
Methods for inhibiting bone loss
|
Filed: 2003-05-27
Issued: 2005-06-14
|
Expired (Term Ended)
Expires: 2012-11-03
|
|
|
US6458811
Benzothiophenes formulations containing same and methods
|
Filed: 1997-03-10
Issued: 2002-10-01
|
Expired (Term Ended)
Expires: 2017-03-10
|
|
|
US6797719
Benzothiophenes, formulations containing same, and methods
|
Filed: 2002-09-05
Issued: 2004-09-28
|
Expired (Term Ended)
Expires: 2017-06-11
|
|
|
US6894064
Benzothiophenes, formulations containing same, and methods
|
Filed: 2004-03-26
Issued: 2005-05-17
|
Expired (Term Ended)
Expires: 2024-03-26
|
|
|
US5478847
Methods of use for inhibiting bone loss and lowering serum cholesterol
|
Filed: 1994-03-02
Issued: 1995-12-26
|
Expired (Term Ended)
Expires: 2014-03-02
|
|
|
US5075321
Methods of treating diseases characterized by interactions of IgG-containing immune complexes with macrophage Fc receptors using antiestrogenic benzothiophenes
|
Filed: 1988-02-24
Issued: 1991-12-24
|
Expired (Term Ended)
Expires: 2008-02-24
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, injunctive relief is barred.
Standard Statutory Term — No obviousness-type double patenting noted.
Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).
Procedural Motions & Interlocutory Orders
Total Motions
274
Dispositive
77
Granted
65
Denied
6
Pending / Review
200
Motions by Category
Key Dispositive Motions & Rulings